Special Issue "Reproductive Health in COVID-19 Era"

A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Obstetrics and Gynecology".

Deadline for manuscript submissions: closed (20 May 2023) | Viewed by 829

Special Issue Editors

Department of Embryology, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece
Interests: reproductive health
Dr. Peter Drakakis
E-Mail Website
Guest Editor
Department of Obstetrics and Gynecology, National and Kapodistrian University of Athens Medical School Attikon Hospital, Athens, Greece
Interests: reproductive health
Dr. Emmanuel N. Kontomanolis
Guest Editor
Department of Obstetrics and Gynecology, Democritus University of Thrace, Alexandroupolis, Greece
Interests: gynecological oncology
Department of Obstetrics and Gynaecology, Faculty of Medicine, School of Health Sciences, University of Thessaly University Hospital, 41110 Larissa, Greece
Interests: reproductive health

Special Issue Information

Dear Colleagues,

Since the COVID-19 pandemic outbreak in 2019, numerous clinical studies have shown that the virus affects almost all human tissues. The months that followed revealed long-term problems such as long COVID syndrome, and other chronic consequences. Except for the heart and respiratory systems, which may be involved in these chronic conditions, other basic human organ functions could be affected. Although most clinical studies have been focused on the virus target organs, the study of the recent literature shows that multiple issues emerge regarding human reproduction and basic reproductive health.The aim of this Special Issue is to provide a collection of articles pertaining to these medical fields as well as COVID-19-affected pregnancy outcomes.

The challenges being faced at the moment include:

  1. COVID-19 and male reproduction problems;
  2. COVID-19 and female reproduction problems;
  3. Effect of COVID-19 on the quantity and quality of gametes;
  4. COVID-19 and assisted infertility techniques;
  5. Dysfunctional uterine bleeding after COVID-19 infection;
  6. Vaccination and dysfunctional uterine bleeding;
  7. Reproductive epidemiology in the COVID-19 era;
  8. Miscarriage and COVID-19 infection;
  9. COVID-19 and early pregnancy complications;
  10. Intrauterine growth restriction in the COVID-19 era;
  11. COVID-19 and preterm labor;
  12. Vaccination in pregnancy.

You are kindly invited to submit your manuscript to this Special Issue of Medicina entitled “Reproductive Health in COVID-19 Era”.

Dr. Sotirios Sotiriou
Dr. Peter Drakakis
Dr. Emmanuel N. Kontomanolis
Prof. Dr. Alexandros Daponte
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • COVID-19
  • reproduction
  • gametes
  • assisted reproduction techniques
  • miscarriage
  • dysfunctional uterine bleeding
  • intrauterine growth restriction
  • preterm labor
  • vaccination

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:


Addressing Chronic Gynecological Diseases in the SARS-CoV-2 Pandemic
Medicina 2023, 59(4), 802; https://doi.org/10.3390/medicina59040802 - 20 Apr 2023
Viewed by 602
Introduction: the COVID-19 pandemic has had a considerable impact on healthcare systems worldwide. Since the actual influence of the pandemic on gynecological care is still unclear, we aim to evaluate the effect of the SARS-CoV-2 pandemic on gynecological procedures compared to the [...] Read more.
Introduction: the COVID-19 pandemic has had a considerable impact on healthcare systems worldwide. Since the actual influence of the pandemic on gynecological care is still unclear, we aim to evaluate the effect of the SARS-CoV-2 pandemic on gynecological procedures compared to the pre-pandemic period in Romania. Materials and Methods: this is a single-center retrospective observational study, involving patients hospitalized in the year before the SARS-CoV-2 pandemic (PP), in the first year of the pandemic (P1), and in the second year of the pandemic until February 2022 (P2). The percentages of interventions were analyzed globally but also according to the type of surgery applied on the female genital organs. Results: during pandemic, the number of gynecological surgeries dropped considerably, by more than 50% in some cases, or even decreased by up to 100%, having a major impact on women’s health, especially in the first year of the pandemic (P1), before slightly increasing in the post-vaccination period (PV). Surgically treated cancer cases dropped by over 80% during the pandemic, and the consequences of this will be seen in the future. Conclusions: the COVID-19 pandemic played an important part in gynecological care management in the Romanian public health care system, and the effect will have to be investigated in the future. Full article
(This article belongs to the Special Issue Reproductive Health in COVID-19 Era)
Show Figures

Figure 1

Back to TopTop